Panel: Don't Screen Older Men for Prostate Cancer

Treatment may be more harmful than helpful after the age of 74

By Peter Fearon, Newser Staff

Posted Aug 5, 2008 2:28 AM CDT

(Newser) – Physicians should stop screening men 75 and older for prostate cancer, according to new guidelines issued by national health task force. Prostate cancer is "overdiagnosed" in up to 44% of cases—that is, the cancer is present but so slow growing that it would... Read full story »

COMMENTS

Read the comment policy

You need to Log in to Newser to comment. Don't have an account yet? Sign up now!

There are no comments

A snapshot of the day's best news stories.

View Larger Grid

All Today Yesterday Pick a Date

What's Popular Now on Facebook

Cops Shoot Naked Guy Eating Man's Face on Highway

Japanese Artist Serves Up Own Cooked Genitals

New York Times (Source Grid »)

US panels questions prostate screening
Washington Post

Not all men need prostate cancer screening
ABC News

Stop prostate tests for men 75 and older?
Chicago Tribune

Science

prostate cancer • American Cancer Society • PSA • American Urological Association • Veterans Administration • prostate-specific antigen • U.S. Preventive Services Task Force • Colorado Department of Public Health and Environment

More Newser Stories

Don't Be Fooled: Prostate Cancer Screening Is Key

Guidelines against PSA testing could cost lives

(NEWSER) - A national task force’s recent warning against prostate cancer screenings in some men could put their lives at risk, cautions physician and researcher William J. Catalona in the Washington Post. “It's important to note that consideration was not given to the overwhelming body of emerging evidence that screening with PSA tests and digital rectal exams saves lives,” Catalona notes. More»

Pill Delivers Prostate Cancer Breakthrough

Daily pill shrinks advanced tumors

(NEWSER) - A new experimental pill taken once a day is proving effective against an advanced, aggressive form of prostate cancer which has resisted other therapies, reports Reuters. The drug, abiraterone, created by Cougar Biotechnology, significantly shrank tumors in a clinical trial, according to a study in the Journal of Clinical Oncology. It could be available by 2011. Prostate cancer is the second-leading cancer killer of men after lung cancer. More»

We Must Reduce Health Care Costs*

*But please don't touch mine, no matter how wasteful

(NEWSER) - The brouhaha over mammograms proves that we’ll never corral health care costs for one simple reason: no one wants to give up any care. Intellectually, women may understand that life-threatening breast cancer is pretty rare before age 50, but rare doesn’t mean non-existent. “Many women would rather be safe than sorry,” writes Eugene Robinson of the Washington Post , “and safe costs money.” More»

Doctors Blast New Mammogram Guidelines

Cancer societies, gynecologists won't follow government's lead

(NEWSER) - There was an instant backlash from oncologists and gynecologists yesterday after a government panel recommended that that women in their 40s stop getting annual mammograms. “I think it is unfortunate that they came to this conclusion,” the director of imaging at one breast cancer center told the Los Angeles Times . “It would be a huge step backwards for women’s health in this country.” Since women in their 40s account for a quarter of breast cancer diagnoses, they fear a reversal in advances in early detection and treatment. More»

Cancer Experts Worried About Screening

American Cancer Society to warn of risks as well as benefits

(NEWSER) - The American Cancer Society is rethinking its advice on screening for breast and prostate cancer amid studies showing that the tests can miss the deadliest forms of the disease, and in some cases lead to dangerous, unnecessary treatment. The society is working on a new message stressing that cancer screening comes with risks as well as benefits, and urging people to make sure they understand both before they are screened. More»

NEWS FROM OUR PARTNERS

What is Newser?

Face it: there's too much news. At Newser, we choose the most thought-provoking and entertaining stories from hundreds of US and international sources and reduce them to a headline, picture, and two paragraphs. And we do it 24/7—you can come back morning, noon, night (and in between) for something new that matters. Read less, know more.

Learn more »

Partnering with: Slate

View Newser on the mobile website

Panel: Don't Screen Older Men for Prostate Cancer

Treatment may be more harmful than helpful after the age of 74

prostate cancer • American Cancer Society • PSA • American Urological Association • Veterans Administration • prostate-specific antigen • U.S. Preventive Services Task Force • Colorado Department of Public Health and Environment

MOST POPULAR STORIES

[ By Views ]

[ By Comments ]

More Newser Stories

Don't Be Fooled: Prostate Cancer Screening Is Key

Guidelines against PSA testing could cost lives

Pill Delivers Prostate Cancer Breakthrough

Daily pill shrinks advanced tumors

We Must Reduce Health Care Costs*

*But please don't touch mine, no matter how wasteful

Doctors Blast New Mammogram Guidelines

Cancer societies, gynecologists won't follow government's lead

Cancer Experts Worried About Screening

American Cancer Society to warn of risks as well as benefits

About Us

Site

Community

Site Maps

Tools

More News

What is Newser?